Austedo XR 36 MG tablet 30S

Ended Awarded

Contract number
SPE2DR26F3F60
Awardee
Awarding agency
Obligated
$53,853

Award facts

Contract value 100% obligated
$53,852.76 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Conshohocken, PA 19428, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency issued a $53,852.76 delivery order to AmerisourceBergen Drug Corp on June 10, 2026, for AUSTEDO XR 36 mg tablets (30 count), with an ultimate completion date of June 11, 2026.

The order is firm fixed price with no set-aside. Place of performance is Conshohocken, PA. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc. and is positioned on the DLA Troop Support Medical Pharmaceutical Prime Vendor Global Program Generation V indefinite delivery contract, a single-award vehicle valued at $4.999 million through December 2036 that supports worldwide military healthcare supply across multiple therapeutic domains.

Quick answers

Who was awarded contract SPE2DR26F3F60?

SPE2DR26F3F60 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 10, 2026.

How much is contract SPE2DR26F3F60 worth?

The government has obligated $53,853 on SPE2DR26F3F60.

Is contract SPE2DR26F3F60 an order under another contract?

Yes. SPE2DR26F3F60 is a delivery order under SPE2DR25D2205, an indefinite delivery contract.

Was contract SPE2DR26F3F60 competed?

The extent of competition for SPE2DR26F3F60 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award